Bisphosphonates inactivate human EGFRs to exert antitumor actions-Reference-Cited by-同舟云学术

Bisphosphonates inactivate human EGFRs to exert antitumor actions

Published:2014-12-01 Issue:50 Volume:111 Page:17989-17994
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Yuen Tony,Stachnik Agnes,Iqbal Jameel,Sgobba Miriam,Gupta Yogesh,Lu Ping,Colaianni Graziana,Ji Yaoting,Zhu Ling-Ling,Kim Se-Min,Li Jianhua,Liu Peng,Izadmehr Sudeh,Sangodkar Jaya,Bailey Jack,Latif Yathin,Mujtaba Shiraz,Epstein Solomon,Davies Terry F.,Bian Zhuan,Zallone Alberta,Aggarwal Aneel K.,Haider Shozeb,New Maria I.,Sun Li,Narla Goutham,Zaidi Mone

Funder

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

HHS | NIH | National Institute on Aging (U.S. National Institute on Aging)

HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference35 articles.

1. Bisphosphonates: The first 40years

2. Seed, soil and secreted hormones: Potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonates

3. Effects of Bone-Targeted Agents on Cancer Progression and Mortality